Features of a twin-arginine signal peptide required for recognition by a Tat proofreading chaperone  by Buchanan, Grant et al.
FEBS Letters 582 (2008) 3979–3984Features of a twin-arginine signal peptide required for recognition
by a Tat proofreading chaperone
Grant Buchanana, Julien Maillardb,1, Sander B. Nabuursc, David J. Richardsonb,
Tracy Palmera, Frank Sargenta,*
a Division of Molecular and Environmental Microbiology, College of Life Sciences, University of Dundee, Dow Street,
Dundee DD1 5EH, Scotland, United Kingdom
b School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, England, United Kingdom
c Centre for Molecular and Biomolecular Informatics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen,
P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
Received 6 October 2008; revised 17 October 2008; accepted 20 October 2008
Available online 12 November 2008
Edited by Stuart FergusonAbstract The twin-arginine translocation (Tat) system is a bac-
terial protein targeting pathway. Tat-targeted proteins display
signal peptides containing a distinctive SRRxFLK twin-arginine
motif. The Escherichia coli trimethylamine N-oxide reductase
(TorA) bears a bifunctional Tat signal peptide, which directs
protein export and serves as a binding site for the TorD biosyn-
thetic chaperone. Here, the physical interaction between TorD
and the TorA signal peptide was investigated. A single substitu-
tion within the TorA signal peptide (L31Q) was suﬃcient to im-
pair TorD binding. Screening of a random torD mutant library
identiﬁed a variant TorD protein (Q7L) that displayed increased
binding aﬃnity for the TorA signal peptide.
Structured summary:
MINT-6796225, MINT-6796279, MINT-6796298, MINT-
6796315, MINT-6796332, MINT-6796350, MINT-6796371,
MINT-6796391, MINT-6796410, MINT-6796429, MINT-
6796446, MINT-6796460:
TorD (uniprotkb:P36662) physically interacts (MI:0218) with
TorA (uniprotkb:P33225) by two-hybrid (MI:0018)
MINT-6796515, MINT-6796563, MINT-6796589, MINT-
6796624, MINT-6796648, MINT-6796666, MINT-6796770,
MINT-6796750:
TorA (uniprotkb:P33225) binds (MI:0407) to TorD (uniprotkb:
P36662) by isothermal titration calorimetry (MI:0065)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Bacterial respiration; Bacterial protein targeting;
Twin-arginine signal peptide; Tat proofreading chaperone;
Protein–protein interaction; Site-directed mutagenesisAbbreviations: Tat, twin-arginine translocation; TMAO, trimethyla-
mine N-oxide
*Corresponding author. Fax: +44 (0)1382 385 893.
E-mail address: f.sargent@dundee.ac.uk (F. Sargent).
1Present address: JM is at ENAC-ISTE/Laboratoire de Biotechnologie
Environnementale (LBE), EPF Lausanne, Baˆtiment Chimie-CHB
Ecublens, CH-1015 Lausanne, Switzerland.
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.10.0491. Introduction
The Tat (twin-arginine translocation) system is a protein tar-
geting pathway found in many prokaryotes [1]. Tat-targeted
proteins are synthesised as precursors with N-terminal signal
peptides containing SRRxFLK twin-arginine motifs [2].
Twin-arginine signal peptides have a tripartite structure
including a polar N-terminal region (n-region), a moderately
hydrophobic region (h-region), and a C-terminal region (c-re-
gion) that often contains a protease cleavage site [2,3]. The
twin-arginine motif is always located at the junction between
the n- and h-regions [1,2]. Proteins bearing Tat signal peptides
are transported by the membrane-bound Tat translocase
machinery, the physiological role of which is to move fully
folded proteins across the cytoplasmic membrane [1].
Escherichia coli produces 27 Tat-targeted proteins [4]. The
majority of these are cofactor-containing enzymes and, in most
cases, these must acquire their prosthetic groups in the cyto-
plasm before export (e.g. [5]). The E. coli trimethylamine N-
oxide (TMAO) reductase (TorA) is a Tat-targeted enzyme that
binds bis-molybdopterin guanine dinucleotide (MGD) as its
single cofactor [6]. Biosynthesis of TorA is governed by TorD,
a member of a chaperone family dedicated to molybdo-pro-
tein assembly [7]. TorD is involved in cofactor loading [8–14]
and also performs a Tat proofreading function, which pre-
vents premature targeting of TorA until all biosynthetic pro-
cesses are complete [15]. Tat proofreading involves a direct,
speciﬁc interaction between TorD and the TorA signal peptide
[15,16], however the mechanism of signal peptide recognition
and release is not fully understood.
In this work, the molecular basis of the interaction between
TorD and the TorA signal peptide has been studied. A leucine-
rich region within the signal peptide h-region is shown to be
involved in TorD binding both in vivo and in vitro. In addi-
tion, a variant, but physiologically active, TorD protein was
identiﬁed that displays increased aﬃnity for native and variant
TorA signal peptides.2. Materials and methods
2.1. Bacterial strains and plasmids
The two-hybrid reporter strain was E. coli BTH101 (cya) [17]. Plas-
mid pSig3 [15] encodes a fusion between the TorA signal peptide (co-
dons 1–42) and the T18 fragment of Bordetella pertussis toxinblished by Elsevier B.V. All rights reserved.
Fig. 2. An L31Q substitution in the TorA signal peptide impairs
in vitro binding by TorD. (A) Calorimetric titration of /MalE-TorAsp
with TorDhis in Tris Æ HCl buﬀer. The best ﬁt to these data gave
n = 0.98 binding sites, DHobs = 10.5 kcal/mol and TDSobs = 0.5 k-
cal/mol. (B) Calorimetric titration of variant /MalE-TorAsp-L31Q
with TorDhis in Tris Æ HCl buﬀer. The best ﬁt to these data gave
n = 0.75 binding sites, DHobs = 12.6 kcal/mol and TDSobs = 4.5 k-
cal/mol. Both experiments were performed under identical conditions
with identical concentrations of proteins. The upper panels show the
raw data for the heat eﬀect during the titrations, and the lower panels
are the binding isotherms.
Fig. 1. Mutagenesis of the TorA signal peptide. (A) Amino acid
sequence of the TorA signal peptide. Substitutions were introduced as
indicated. (B) Interactions between TorD and amino acid-substituted
TorA signal peptides measured in vivo using a bacterial two-hybrid
system. Vectors pT25-TorD and pSig3 variants, encoding a TorA–T18
fusion, were co-transformed into BTH101 and b-galactosidase activity
determined. Native indicates the unmodiﬁed TorA signal peptide, and
the column marked T18 + T25 is the negative control. The error bars
represent the standard error of the mean, n = 3.
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and a random mutant library was constructed in this vector using er-
ror-prone PCR [18]. Approximately 42,600 mutant clones were ob-
tained at an error rate of 1.35%. Plasmid pQM-TorAsp [19] produces
the TorA signal peptide (residues 1–42), as a C-terminal fusion to ma-
ture maltose binding protein (MalE). Overproduction of TorDhis was
from pQI-TorD, which harbors a mutant torD where codons 2–6 have
been replaced by highest-usage codons for the same amino acids. For
constitutive torD expression pUP-TorD [15], and its Q7L derivative
pUNI-Q7L, were used.Strains carrying chromosomal mutations in torA were constructed
by mutagenising the torA sequence present in pTor1 [20]. The torA
L31Q allele was moved into pMAK705 [21] and recombined onto
the MC4100 chromosome to yield GB430. The DtorD allele from
FTD100 [15] was introduced into GB430 using the method of Hamil-
ton et al. [21] to give strain GB430-D.
Strain RJ607-M was constructed by moving the DmoaA::ApraR al-
lele from MC4100moaA (B. Ize and T. Palmer – unpublished) by P1
transduction into RJ607 [15]. FTD100 (DtorD) has been described
[15], and GB420 (as MC4100, DtorA) was constructed by assembling
a DtorA allele in pMAK705 before replacement of the native gene
on the chromosome as described [21].
Site-directed mutagenesis was by Quikchange (Stratagene) and all
clones were sequenced. During genetic manipulations E. coli was
grown aerobically in Luria-Bertani (LB) medium [22]. Physiological
characterisations were carried out on strains grown anaerobically in
LB supplemented with 0.5% (v/v) glycerol and either 0.4% (w/v)
TMAO or 0.4% (w/v) fumarate.
2.2. Protein methods
Overproduction and puriﬁcation of TorDhis and /MalE-TorAhis
was as described [19,23]. Subcellular fractionations were performed
by a lysozyme/EDTA method [24]. TMAO::benzyl viologen (BV) oxi-
doreductase and Hydrogen::BV oxidoreductase activities was mea-
sured as described [15,25]. SDS–PAGE and Western immunoblotting
was as described [26,27]. Antisera to the TorA signal peptide (residues
2–16) was generated by Severn Biotech (Kidderminster, UK), while
anti-TorA and anti-TorD and sera were as described [15,28]. Interac-
tions detected by the bacterial two-hybrid system were quantiﬁed by
b-galactosidase activity [17] in the BTH101 grown aerobically to
mid-log phase at 30 C in LB medium.
2.3. Isothermal titration calorimetry
ITC was performed in 50 mM Tris Æ HCl (pH 7.5) at 28 C in a VP-
ITC microcalorimeter (MicroCal Inc.). TorDhis (100 lM) was loaded
into the syringe, while the sample cell contained 10 lM /MalE::TorAhis
fusion protein. Titrations consisted of 35 · 8 ll injections of TorDhis.
Data analysis was performed with Origin software (MicroCal Inc.).
2.4. Molecular modeling of the TorD monomer
Homology modeling techniques were used to construct a three-
dimensional model of the E. coli TorD monomer. The structure of
TorD from Shewanella massilia [29] was used as a modeling template.
This dimeric crystal structure (1N1C) was solved at 2.4 A˚ resolution
and sequence identity between template and model sequence was
32% over 170 aligned residues. To construct a TorD monomer the
loops between helix 6 and helix 7, which link the two globular units
forming the dimer, and one of the two globular units were deleted.
The now missing loop between helix 6 and helix 7 was modeled on
the two remaining partial protein chains to form the E. coli TorD
monomer. All loops were modeled using the YASARA program
(http://www.yasara.org) by searching a non-redundant subset of the
protein data bank for loops with similar sequence and start and end
anchor points. Subsequently, side-chains were modeled and the model
was optimized using the Yamber2 force ﬁeld [30]. A coordinate ﬁle of
the model is available from the authors upon request.3. Results
3.1. Glutamine-scanning mutagenesis of the hydrophobic region
of the TorA signal peptide
An initial study of TorA signal peptide binding by TorD
indicated that recognition involved the hydrophobic h-region
[16]. In order to rapidly assess the roles of TorA h-region
side-chains in TorD binding, a program of mutagenesis using
a bacterial two-hybrid system was undertaken. Cristo´bal
et al. [3] demonstrated that glutamine occurred rarely in Tat
signal peptide h-regions, thus TorA residues L18 through
L32 were substituted individually with glutamine and the
TorD interaction observed (Fig. 1A).
Table 1
Native TorA peptide binding aﬃnities measured in vitro by ITC.
Peptide TorD Kd (nM) DDG
a (kcal/mol) Ratio
Native TorA Native TorD 59 ± 5 – 1
Native TorA Q7L TorD 21 ± 1 0.6 0.4
Native TorA F180L TorD 177 ± 9 0.7 3
Native TorA L189Q TorD 163 ± 10 0.6 2.8
aThe diﬀerence in free energy change is given by DDG = RT
ln(Kd(variant)/Kd(native)).
Table 2
Variant L31Q peptide binding aﬃnities measured in vitro by ITC.
Peptide TorD Kd (nM) DDG
a (kcal/mol) Ratio
L31Q TorA Native TorD 1147 ± 172 – 1
L31Q TorA Q7L TorD 467 ± 20 0.5 0.4
L31Q TorA F180L TorD 765 ± 52 0.2 0.7
L31Q TorA L189Q TorD 882 ± 54 0.2 0.8
aThe diﬀerence in free energy change is given by DDG = RT
ln(Kd(variant)/Kd(native)).
Fig. 3. Physiological activity of the TorA L31Q and TorD Q7L
variants. E. coli strains MC4100 (parent strain; designated WT),
GB420 (DtorA), GB430 (torA L31Q; L31Q), GB430-D (DtorD, torA
L31Q; L31Q DtorD), FTD100 (DtorD), and FTD100 transformed
with pUP-TorD (+TorD) or pUNI-Q7 L (+Q7L) were cultured
anaerobically in LB medium supplemented with 0.5% (v/v) glycerol
and 0.4% (w/v) TMAO before being fractionated into periplasmic (p,
black bars), total membranes (m, grey bars) and cytoplasmic (c, white
bars) fractions. TMAO:BV oxidoreductase activity were then deter-
mined. Activity is expressed as lmol of benzyl viologen oxidized per
minute per gram of cells. The error bars represent S.E.M. (n = 3). (B)
Strains FTD100 (DtorD) and GB430-D (DtorD, torA L31Q) were
transformed separately with pUP-TorD, encoding native TorD
(+TorD), and pUNI-Q7L, encoding the Q7L derivative of TorD
(+Q7L). Strains were grown anaerobically in LB medium supple-
mented with 0.5% (v/v) glycerol and 0.4% (w/v) TMAO before being
fractionated into periplasm and sphaeroplast fractions. Equivocal
amounts of each fraction were then separated by SDS–PAGE, blotted,
and challenged either with an anti-TorA serum (1:5000 dilution), an
anti-TorA signal peptide serum (1:1000 dilution), or an anti-TorD
serum (1:5000 dilution). (C) TorD-dependent Tat proofreading assay.
Strains RJ607 (/TorA-HybO) and RJ607-M (/TorA-HybO,
DmoaA) were transformed with empty vector (basal), pUP-TorD
encoding native TorD (+TorD) or pUNI-Q7L encoding the Q7L
derivative of TorD (+Q7L). Cultures were grown anaerobically in LB
medium supplemented with 0.5% (v/v) glycerol and 0.4% (w/v)
fumarate, washed, and suspended in 10mM Tris–HCl (pH 7.5). Intact
cells were assayed for hydrogen::benzyl viologen oxidoreductase
activity. Error bars indicate S.E.M. (n = 3).
G. Buchanan et al. / FEBS Letters 582 (2008) 3979–3984 3981Mutations were introduced into plasmid pSig3 [15], which
when co-expressed with pT25-TorD in the E. coli cya strain
BTH101 allows the detection of the TorA–TorD interaction
in vivo (Fig. 1B). Substitutions of TorA G19, G20, V23,
G28, L27, L31 and L32 with glutamine resulted in low levels
of b-galactosidase activity (Fig. 1B). Indeed, the L31Q and
L32Q variants of the TorA signal peptide displayed essentially
undetectable levels of interaction with TorD (Fig. 1B). Thus
regions of the TorA signal peptide important in binding, in
particular a leucine-rich segment at the C-terminus including
L27, G28, L31 and L32, were identiﬁed (Fig. 1B).
3.2. The L31Q variant of the TorA signal peptide is impaired in
TorD binding
Isothermal Titration Calorimetry (ITC) [16,19] was used to
compare and contrast the apparent dissociation constants
(Kds) for the interaction between TorD and the TorA L31Q
variant signal peptide. Titration of the native TorA signal pep-
tide with puriﬁed TorD resulted in a sigmoidal binding curve
that reached a clear saturation point (Fig. 2A) resulting in
an apparent Kd of 59 nM (Table 1). Titration of TorD against
a MalE-TorA fusion protein bearing the L31Q substitution,
which showed a negligible interaction with TorD in vivo
(Fig. 1B), suggests these proteins can still interact in vitro
(Fig. 2B). However, the best ﬁt to the L31Q TorA–TorD data
(Fig. 2B) gives an apparent Kd of 1147 nM (Table 2).
3.3. The L31Q variant of the TorA signal peptide is transport
active
To test the physiological eﬀect of the TorA L31Q substitu-
tion on the biosynthesis of the native enzyme, a strain
(GB430) was constructed that would produce a modiﬁed TorA
protein at native levels. The amount of periplasmic TMAO
reductase activity, and the location of the TorA polypeptide,
were not aﬀected by the L31Q substitution (Fig. 3A and B).
Taken together, these data suggest that while residue L31 is
important for signal peptide recognition by TorD, it is not crit-
ical for the Tat transport activity of the TorA signal sequence.
3.4. Isolation of TorD variants that show enhanced recognition
for TorA L31Q
A genetic screen was undertaken to isolate TorD proteins
that could interact with the L31Q TorA variant signal peptide.
The screen was based on the bacterial two-hybrid system and
strain BTH101 was co-transformed with the plasmid encoding
TorA L31Q-T18 and a random library of torD mutants in
pT25. Positive interactors were detected on MacConkey malt-
ose indicator plates (where red colonies indicate an interac-
tion), and ultimately two torD clones from an estimated
60000 transformants were isolated that consistently produced
red colonies in this test. The two positive suppressor clones
were designated Supp1, which encoded a variant TorD
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and Supp2, which encoded a TorD protein carrying a single
Q186L substitution.
3.5. A Q7L substitution in TorD increases its aﬃnity for signal
peptides
b-galactosidase assays suggested Supp1 could maintain a
more signiﬁcant interaction with the TorA L31Q signal peptide
than Supp2 in the in vivo two-hybrid test (Fig. 4A). More-
over, b-galactosidase activities suggested tighter interactions
were possible between both Supp1 and Supp2 and the native
TorA signal peptide than observed for the native TorD protein
(Fig. 4B).
Next, the four Supp1 and Supp2 point mutations were
separately incorporated into overexpression vector pQI-TorD.
The variant TorD protein encoded by Supp2 (Q186L) proved
recalcitrant to puriﬁcation and further characterization was
not possible. The TorD variants Q7L, F180L, and L189Q,
however, were tested for their ability to interact with the TorA
signal peptide in vitro. ITC demonstrated that the F180L and
L189Q variants showed slight increases in aﬃnity for the TorA
L31Q signal peptide relative to native TorD (Table 2). The
Q7L TorD variant, however, exhibited a signiﬁcant increase
in aﬃnity for the TorA L31Q signal peptide (Table 2). While
the F180L and L189Q TorD variants were found to bind less
tightly than native TorD to the native TorA signal peptide (Ta-
ble 1), the Q7L TorD variant again exhibited a notably higher
aﬃnity for the native TorA signal peptide (Table 1). Thus the
TorD Q7L substitution generates a protein that binds more
tightly in general to signal peptides, rather than compensating
directly for the L31Q substitution in the variant signal peptide.
3.6. The TorD Q7L variant is physiologically active
The physiological activity of the variant TorD Q7L protein
was assessed. The ability of TorD Q7L to complement a DtorDFig. 4. Isolation of variant TorD proteins that recognize the TorA
L31Q signal peptide. Interactions between TorD and TorA signal
peptides measured using a bacterial two-hybrid system [15,17]. A.
BTH101 was co-transformed with vectors encoding either native TorD
(pT25-TorD) or variant TorD proteins (Supp1 and Supp2) with
plasmid pSig3-L31Q encoding a fusion to TorA L31Q. (B) BTH101
was co-transformed with vectors encoding either native TorD (pT25-
TorD) or variant TorD proteins (Supp1 and Supp2) with plasmid
pSig3 encoding a fusion to native TorA. Error bars represent S.E.M.
(n = 3).strain was examined and the variant protein indeed retained its
biological activity and was able to rescue TMAO reductase
levels to normal levels (Fig. 3A). Because of the increased bind-
ing aﬃnity for TorA exhibited by the TorD Q7L variant, it
was possible that a portion of tightly-bound chaperone could
be exported to the periplasm in tandem with the TMAO reduc-
tase. Western analysis demonstrated, however, that neither the
native TorD protein nor the Q7L variant was exported to the
periplasm under any conditions tested (Fig. 3B).
An E. coli reporter strain has been described that allows the
assay of the Tat proofreading activity of TorD [15]. The RJ607
strain expresses a chimeric hydrogenase enzyme bearing the
TorA signal peptide and displays a low intrinsic hydrogenase
activity that can be boosted through co-expression of an active
torD gene [15]. Use of this assay demonstrated that the TorD
Q7L variant retained its Tat proofreading activity in vivo
(Fig. 3C).4. Discussion
In this work, single side-chain modiﬁcations of the TorA sig-
nal peptide h-region are shown to be suﬃcient to disrupt binding
by TorD. Combined genetic and biophysical approaches point
to a leucine-rich hotspot for TorD binding comprising L27,
G28, L31, and L32. As with recent examples of tight protein–
protein interactions [31], it is possible that the critical hydropho-
bic leucine residues of TorA identiﬁed here may become buried
upon binding by TorD. Indeed, the ITC experiments point to a
diﬀerence in free energy change (DDG [DDG = RT ln(Kd(vari-
ant)/Kd(native)]) of +1.8 kcal/mol for TorD binding to the na-
tive versus the L31Q variant TorA signal peptide. This is
caused by a combination of a decrease in enthalpy (DH) of bind-
ing (2.1 kcal/mol), indicative of an increase in hydrogen bond-
ing, together with a decrease in entropy (TDS) of binding
(4.0 kcal/mol), perhaps indicating a reduced hydrophobic
eﬀect. While the structure of the TorA signal peptide h-region
in free or TorD-bound form is unknown, helical wheel projec-
tions of the h-region suggest a broad TorD-interacting face if
plotted as a canonical a-helix (Fig. 5A), or a neater interacting
face if plotted as a coiled-coil (Fig. 5B).
TorD Q7L is capable of recognizing a signal peptide bearing
the L31Q change. The Q7 residue is conserved across the TorD
family and interchangeable with asparagine or aspartate in
nature [29,32–34]. Available 3D structures of TorD family pro-
teins show an all-helical fold arranged into 2 domains con-
nected by a linker [29]. Sh. massilia TorD forms a
homodimer where the N-terminal domain of one protomer
packs onto the C-terminal domain of another (Fig. 5C. and
ref. [29,33,34]). However, all other TorD structures are mono-
meric and the signal peptide binding studies of E. coli TorD
are also performed on the monomer. Thus a 3D model of
the E. coli TorD monomer was built (Fig. 5D and E). The
E. coli TorD Q7 residue (equivalent to N7 of the Sh. massilia
TorD) is located at the beginning of the ﬁrst a-helix (Fig. 5E).
Helix 1 is important in forming the helix bundle core [29] and
makes extensive contacts with helix 10 [29]. Indeed, the other
amino acid substitutions that had some inﬂuence on peptide
binding eﬃcacy are located on helix 10 (Fig. 5E). It is possible,
therefore, that the Q7L substitution is modifying the interac-
tion between the TorD domains and thus having a long-range
eﬀect on the nature of the signal peptide binding site. Alterna-
Fig. 5. Models of the TorA signal peptide and the TorD monomer.
(A) Helical wheel projection of the TorA h-region as a canonical a-
helix (3.6 residues per turn). (B) Helical wheel projection of the TorA
h-region with 3.9 residues per turn. Residues implicated in TorD
binding by in vivo and in vitro interaction analysis are colored red. The
projections were drawn using the on-line tool available from the
University of California, Riverside, at http://rzlab.ucr.edu/scripts/
wheel/wheel.cgi. (C) Topology of the domain-swapped Sh. massilia
TorD dimer [29]. Helices are drawn as rectangles and are numbered
sequentially for each of the 2 polypeptide chains (colored red and
turquoise). The secondary structure elements that together form a
globular domain are indicated using the grey boxes and the loops
joining the two globular domains are indicated with dashed lines. (D)
Topology of the modeled E. coli TorD monomer. A new loop,
indicated in purple, is modeled between helix 6 and helix 7 to create a
complete monomeric TorD model. (E) A structure model of the E. coli
TorD monomer. The N-terminal helix 1 is shown in cyan and the C-
terminal helix 10 in yellow. The loop between helices 6 and 7 is shown
in pink. Residue Q7 is highlighted in orange, F180 in blue, and L189 in
purple. The ribbon diagram was drawn using PyMol.
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regulatory molecule. For example, the crystal structure of
DmsD from Salmonella enterica serovar Typhimurium sug-
gests the Q7 equivalent (D8) may be located in a novel GTP
binding site [34], and GTP binding was previously shown to
inﬂuence signal peptide aﬃnity of TorD [16]. Moreover, Gen-
est et al. [9] showed recently that TorD could also bind the
MGD cofactor in vitro. To examine the role of MGD in the
Tat proofreading process, the RJ607 reporter strain expressing
the TorA-hydrogenase fusion [15] was modiﬁed by the addi-
tion of a DmoaA allele, which would result in a bacterial strain
completely devoid of MGD [35]. Production of either native
TorD, or the Q7L variant, in the cofactor-less reporter strain
established that MGD has no essential role in the Tat proof-
reading activity of TorD (Fig. 3C).In conclusion, this work has identiﬁed key structural fea-
tures of a Tat signal peptide required for its recognition and
binding by a Tat proofreading chaperone. These features ap-
pear to be distinct from those involved in Tat targeting and
suggests these two processes may not be mutually exclusive.
In addition, a variant TorD chaperone has been identiﬁed with
an enhanced aﬃnity for its peptide ligand. Both of these ﬁnd-
ings will facilitate future studies into the structure and function
of the paradigmatic TorD to TorA signal peptide interaction.
The next issues to address are whether there is an induced sec-
ondary structure imposed on the TorA signal peptide upon
TorD binding, and exactly where on the TorD surface the
key TorA residues are binding.
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